Collplant
๐ฎ๐ฑIsrael
- Country
- ๐ฎ๐ฑIsrael
- Ownership
- -
- Employees
- 75
- Market Cap
- -
- Introduction
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
VergenixTM Flowable Gel in Patients With Lower Limb Ulcers
Not Applicable
Completed
- Conditions
- Lower Limb Ulcers
- Interventions
- Device: VergenixTM Flowable Gel
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Collplant
- Target Recruit Count
- 20
- Registration Number
- NCT02598180
- Locations
- ๐ฎ๐ฑ
Maccabi Health Care, Tel Aviv, Israel
๐ฎ๐ฑAssaf Harofeh, Zrifin, Israel
Tissue Repair Device (VergenixTM STR) in Patients With Epicondylitis (Tennis Elbow)
Not Applicable
Completed
- Conditions
- Non Ruptured Tendon InjuriesTendinopathy
- Interventions
- Device: Tissue Repair Device (VergenixTM STR)
- First Posted Date
- 2014-12-05
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Collplant
- Target Recruit Count
- 40
- Registration Number
- NCT02309307
- Locations
- ๐ฎ๐ฑ
Hadassah MC, Jerusalem, Israel
๐ฎ๐ฑMeir MC, Kfar Saba, Israel
๐ฎ๐ฑAssaf Harofeh MC, Zrifin, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath